| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 28593-30-8 | Carbamicacid, [1-[(hexylamino)carbonyl]-1H-benzimidazol-2-yl]-, methyl ester (9CI); 2-Benzimidazolecarbamicacid, 1-(hexylcarbamoyl)-, methyl ester (8CI) |  | C16H22N4O3 | 詳情 | 供應商 | |
| 88107-10-2 | Ethanone,1-[2-hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)butoxy]phenyl]-; Ethanone,1-[2-hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)butoxy]phenyl]- (9CI); LY 171883; Tomelukast |  | C16H22N4O3 | 詳情 | 供應商 | |
| 133058-72-7 | 1H-Purine-2,6-dione,3,9-dihydro-8-(3-oxocyclopentyl)-1,3-dipropyl-; 1H-Purine-2,6-dione,3,7-dihydro-8-(3-oxocyclopentyl)-1,3-dipropyl- (9CI); KFM 19 |  | C16H22N4O3 | 詳情 | 供應商 | |
| 151581-23-6 | 1H-Purine-2,6-dione,3,9-dihydro-8-[(1S)-3-oxocyclopentyl]-1,3-dipropyl-; 1H-Purine-2,6-dione,3,7-dihydro-8-(3-oxocyclopentyl)-1,3-dipropyl-, (S)-; 1H-Purine-2,6-dione,3,7-dihydro-8-[(1S)-3-oxocyclopentyl]-1,3-dipropyl- (9CI); Apaxifylline; BIIP20XX |  | C16H22N4O3 | 詳情 | 供應商 | |
| 63931-80-6 | 1H-1,2,4-Benzotriazepine-3-carboxylicacid, 4,5-dihydro-4-methyl-5-oxo-, 2-(diethylamino)ethyl ester |  | C16H22N4O3 | 詳情 | 供應商 | |
| 5069-56-7 | 2-Quinoxalinecarboxamide,N-[3-(diethylamino)propyl]-, 1,4-dioxide |  | C16H22N4O3 | 詳情 | 供應商 | |
| 124963-19-5 | 5H-1,2,4-Triazolo[4,3-a][1,4]diazepine,6,7,8,9-tetrahydro-8-methyl-3-(3,4,5-trimethoxyphenyl)- |  | C16H22N4O3 | 詳情 | 供應商 | |
| 125008-48-2 | 5H-1,2,4-Triazolo[4,3-d][1,4]diazepine,6,7,8,9-tetrahydro-7-methyl-3-(3,4,5-trimethoxyphenyl)- |  | C16H22N4O3 | 詳情 | 供應商 |